Valuation: Apex Biotechnology Corp.

Market Cap 2.92B 88.67M 80.35M 74.32M 67.06M 126M 8.36B 131M 893M 354M 4.47B 333M 326M 14.18B P/E 2024
23.7x
P/E 2025 18.8x
Enterprise Value 2.38B 72.43M 65.63M 60.71M 54.77M 103M 6.83B 107M 729M 289M 3.65B 272M 266M 11.58B EV / Sales 2024
1.37x
EV / Sales 2025 1.29x
Free-Float
62.14%
Yield 2024
3.99%
Yield 2025 4.27%
1 day+2.46%
1 week+1.21%
Current month+0.69%
1 month-2.99%
3 months-5.19%
6 months+1.39%
Current year-4.11%
1 week 28.3
Extreme 28.3
30
1 month 28
Extreme 28
30.35
Current year 28
Extreme 28
33.1
1 year 28
Extreme 28
33.1
3 years 26.4
Extreme 26.4
44.45
5 years 22.9
Extreme 22.9
44.45
10 years 17.3
Extreme 17.3
44.45
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 18/01/2011
Chief Administrative Officer - -
Director TitleAgeSince
Chairman - 18/01/2011
Director/Board Member - 18/01/2011
Director/Board Member - 25/05/2018
Change 5-day change 1-year change 3-year change Capi.($)
+2.46%+1.21%-5.04%+8.15% 88.67M
+1.18%-1.28%-16.90%+11.78% 188B
+1.85%+1.04%+7.29%+41.70% 126B
-0.88%-4.98%-14.52%+9.40% 118B
+1.36%-5.91%-42.82%+1.32% 92.48B
+2.96%+7.64%-0.80%+84.71% 68.51B
+1.08%+2.90%+12.95%-6.56% 59.39B
+0.89%+4.17%+2.07%+55.03% 55.48B
-0.68%+6.83%-1.08%+55.36% 49.62B
+1.79%+0.10%-0.55%-8.36% 35.17B
Average +1.20%+0.73%-5.94%+25.25% 79B
Weighted average by Cap. +1.04%-0.38%-9.05%+24.75%

Financials

2024 2025
Net sales 1.85B 56.27M 51M 47.17M 42.56M 80.2M 5.31B 83.03M 567M 225M 2.83B 211M 207M 9B 1.94B 59.09M 53.55M 49.53M 44.69M 84.21M 5.57B 87.18M 595M 236M 2.98B 222M 217M 9.45B
Net income 128M 3.89M 3.52M 3.26M 2.94M 5.54M 367M 5.74M 39.16M 15.53M 196M 14.59M 14.28M 622M 163M 4.95M 4.48M 4.15M 3.74M 7.05M 467M 7.3M 49.83M 19.76M 249M 18.57M 18.18M 791M
Net Debt -476M -14.46M -13.1M -12.12M -10.93M -20.6M -1.36B -21.33M -146M -57.72M -728M -54.25M -53.1M -2.31B -535M -16.25M -14.72M -13.62M -12.29M -23.15M -1.53B -23.97M -164M -64.86M -818M -60.96M -59.67M -2.6B
Projected Income Statement - Annual - Apex Biotechnology Corp.
Logo Apex Biotechnology Corp.
APEX BIOTECHNOLOGY CORP is a Taiwan-based company principally engaged in the research, development, manufacture and distribution of testing strips, electrode testing strips and tester suites. The Company primarily provides testing strips and monitoring systems, including blood glucose monitoring systems, uric acid monitoring systems, pesticide residue detection systems, lactate monitoring systems and hemachrome testing systems, among others. Its blood glucose monitoring systems and uric acid monitoring systems are mainly used by patients, doctors and nurses in hospitals and clinics. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and the rest of Asia.
Employees
-
Date Price Change Volume
13/11/26 NT$29.20 +2.46% 161,457
12/11/26 NT$28.50 -0.35% 45,360
11/11/26 NT$28.60 +0.18% 60,318
10/11/26 NT$28.55 -0.70% 75,254
09/11/26 NT$28.75 -0.35% 70,557

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Apex Biotechnology Corp.
  1. Stock Market
  2. Stocks
  3. 1733 Stock